Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
seizure; This serious case was reported by a consumer and described the occurrence of seizure in a female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced seizure (Verbatim: seizure) (serious criteria GSK medically significant). The outcome of the seizure was resolved. It was unknown if the reporter considered the seizure to be related to Shingrix. The company considered the seizure to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 03-FEB-2025 Consumer commented that they had a seizure response to the first dose of the Shingrix vaccine. The reporter also mentioned that yes, even people should be cautious, because drugs were tested on rats before. She was personally know (as a woman) that my seizure response to the shingrix vax wasn't reported, as she kept getting text reminders to get the second one.; Sender's Comments: Seizure is an unlisted event which is considered unrelated to GSK vaccine Shingrix.